18/03/2025
A 45-year-old man with HIV is started on an antiretroviral regimen containing tenofovir, emtricitabine, and dolutegravir. Three months later, he presents with new-onset lower back pain and difficulty walking. Lab results show:
• Serum creatinine: 2.1 mg/dL (↑)
• Urinalysis: Proteinuria, normoglycemic glycosuria, phosphaturia
• Serum phosphate: Low
• Bone density scan: Osteomalacia
Which of the following is the most likely cause of this patient’s symptoms?
A. Dolutegravir-induced myopathy
B. Emtricitabine-induced hypersensitivity
C. Tenofovir-induced renal toxicity
D. Immune reconstitution inflammatory syndrome (IRIS)
E. Opportunistic infection-related osteomyelitis